Diagnostic accuracy of follow-up tests for detecting colorectal cancer recurrences in primary care: A systematic review and meta-analysis

被引:6
作者
Liemburg, Geertje B. [1 ]
Brandenbarg, Daan [1 ]
Berger, Marjolein Y. [1 ]
Duijts, Saskia F. A. [1 ]
Holtman, Gea A. [1 ]
de Bock, Geertruida H. [2 ]
Korevaar, Joke C. [3 ]
Berendsen, Annette J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[3] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands
关键词
Colorectal cancer; follow‐ up care; primary care; recurrences; CARCINOEMBRYONIC ANTIGEN LEVELS; SURVEILLANCE; RESECTION; COLON; CEA; SURVIVAL; SURGERY; TRENDS; MODEL;
D O I
10.1111/ecc.13432
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction Traditionally, follow-up of colorectal cancer (CRC) is performed in secondary care. In new models of care, the screening part care could be replaced to primary care. We aimed to synthesise evidence on the diagnostic accuracy of commonly used screeners in CRC follow-up applicable in primary care: carcinoembryonic antigen (CEA), ultrasound and physical examination. Methods Medline, EMBASE, Cochrane Trial Register and Web of Science databases were systematically searched. Studies were included if they provided sufficient data for a 2 x 2 contingency tables. QUADAS-2 was used to assess methodological quality. We performed bivariate random effects meta-analysis, generated a hypothetical cohort, and reported sensitivity and specificity. Results We included 12 studies (n = 3223, median recurrence rate 19.6%). Pooled estimates showed a sensitivity for CEA (<= 5 mu g/l) of 59% [47%-70%] and a specificity of 89% [80%-95%]. Only few studies reported sensitivities and specificities for ultrasound (36-70% and 97-100%, respectively) and clinical examination (23% and 27%, respectively). Conclusion In practice, GPs could perform CEA screening. Radiological examination in a hospital setting should remain part of the surveillance strategy. Personalised algorithms accounting for recurrence risk and changes of CEA-values over time might add to the diagnostic value of CEA in primary care.
引用
收藏
页数:11
相关论文
共 46 条
[21]  
Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2700, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2535]
[22]   High efficacy and patient satisfaction with a nurse-led colorectal cancer surveillance programme with 10-year follow-up [J].
Moloney, Jayson ;
Partridge, Carolynne ;
Delanty, Sue ;
Lloyd, David ;
Nguyen, M. Hung .
ANZ JOURNAL OF SURGERY, 2019, 89 (10) :1286-1290
[23]   Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities [J].
Nekhlyudov, Larissa ;
O'Malley, Denalee M. ;
Hudson, Shawna V. .
LANCET ONCOLOGY, 2017, 18 (01) :E30-E38
[24]   Blood CEA levels for detecting recurrent colorectal cancer [J].
Nicholson, Brian D. ;
Shinkins, Bethany ;
Pathiraja, Indika ;
Roberts, Nia W. ;
James, Tim J. ;
Mallett, Susan ;
Perera, Rafael ;
Primrose, John N. ;
Mant, David .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (12)
[25]  
Nicolini A., 2010, ARCH SURG CHICAGO IL, V145, p1177
[26]  
Peters F.T.M., 2014, LANDELIJKE RICHTLIJN
[27]   Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer The FACS Randomized Clinical Trial [J].
Primrose, John N. ;
Perera, Rafael ;
Gray, Alastair ;
Rose, Peter ;
Fuller, Alice ;
Corkhill, Andrea ;
George, Steve ;
Mant, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (03) :263-270
[28]  
Reitsma J., 2009, COCHRANE HDB SYSTEMA
[29]   Intensive Follow-Up After Curative Surgery for Colorectal Cancer [J].
Rodrigues, Rita Vale ;
da Silva, Joao Pereira ;
Rosa, Isadora ;
Santos, Isabel ;
Pereira, Nuno ;
Soares, Carla ;
Pereira, Antonio Dias .
ACTA MEDICA PORTUGUESA, 2017, 30 (09) :633-641
[30]   A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma [J].
Rosati, G. ;
Ambrosini, G. ;
Barni, S. ;
Andreoni, B. ;
Corradini, G. ;
Luchena, G. ;
Daniele, B. ;
Gaion, F. ;
Oliverio, G. ;
Duro, M. ;
Martignoni, G. ;
Pinna, N. ;
Sozzi, P. ;
Pancera, G. ;
Solina, G. ;
Pavia, G. ;
Pignata, S. ;
Johnson, F. ;
Labianca, R. ;
Apolone, G. ;
Zaniboni, A. ;
Monteforte, M. ;
Negri, E. ;
Torri, V. ;
Mosconi, P. ;
Fossati, R. .
ANNALS OF ONCOLOGY, 2016, 27 (02) :274-280